基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the detailed record of transactions filed by Hanham Ann, 董事. Director active across 1 company, notably SCYNEXIS INC. In total, 4 disclosures have been recorded. History available since 17 June 2022. The latest transaction was disclosed on 20 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Ann Hanham is a Board Member at SCYNEXIS INC. She contributes to the governance of the company and to defining its strategy. With her experience in the biopharmaceutical sector, she plays a key role in decision-making that promotes growth and innovation.